Abstract

In the first year of the COVID-19 pandemic, Australia had <30,000 COVID-19 cases. Formerly stringent public health measures are now relaxed and vaccinations are available. We compared pandemic impacts on Victorians with HIV (people with HIV [PWHIV]) over time. Two surveys were developed with HIV stakeholder groups appraising demographics, concern, and pandemic impacts. The latter included vaccination, mental health, and quality of life questions. Recruitment was through social media and Alfred and Monash Health HIV-clinics (first survey August 26 to November 26, 2020; second survey October 30, 2021 to January 31, 2022). The surveys had 153 and 95 respondents, respectively. Demographics were similar. Most reported negatively impacted mental health (68%). Most (56%) required mental health services, of these, 39% could not access them. Rates of concern increased. Ninety percent had two COVID-19 vaccinations. Both surveys demonstrated HIV and non-HIV-care provision. PWHIV reported concern and negative impacts. Improved mental health services access is needed to optimize PWHIV quality of life.

Get full access to this article

View all available purchase options and get full access to this article.

References

2. Blumenthal D, Fowler EJ, Abrams M, et al. Covid-19—Implications for the health care system. N Engl J Med 2020;383(15):1483–1488;
3. Weerasuria M, Ko C, Ehm A, et al. The impact of the COVID-19 pandemic on people living with HIV in Victoria, Australia. AIDS Res Hum Retroviruses 2021;37(4):322–328;
4. Australian Government Department of Health. Coronavirus (COVID-19) Case Numbers and Statistics. 2022. Available from: https://www.health.gov.au/health-alerts/covid-19/case-numbers-and-statistics [Last accessed: February 22, 2022].
5. PozQol. About PozQol. 2022. Available from: https://www.pozqol.org/about-pozqol/ [Last accessed: February 22, 2022].
6. Power J, et al. HIV Futures 9, Latrobe University, 2019; pp. 16–17 used. Available from: https://www.latrobe.edu.au/arcshs/publications/hiv-futures-publications [Last accessed: February 22, 2022].
7. Abdullah F, Myers J, Basu D, et al. Decreased severity of disease during the first global omicron variant COVID-19 outbreak in a large hospital in Tshwane, South Africa. Int J Infect Dis. 2021 Dec 28;116:38–42;
8. Australian Government Department of Health 2022. COVID-19 Vaccine Rollout Update—January 31, 2022. Available from: https://www.health.gov.au/resources/publications/covid-19-vaccine-rollout-update-31-january-2022 [Last accessed: February 22, 2022].
9. Murphy D, et al. COVID-19 vaccine acceptability among people living with HIV (PLHIV) and PrEP users. The Joint Australasian HIV&AIDS + Sexual Health Conferences, Virtual Conference, September 6–8, 2021
10. Vallée A, Fourn E, Majerholc C, et al. COVID-19 vaccine hesitancy among French people living with HIV. Vaccines (Basel) 2021;9(4):302;

Information & Authors

Information

Published In

cover image AIDS Research and Human Retroviruses
AIDS Research and Human Retroviruses
Volume 38Issue Number 11November 2022
Pages: 875 - 877
PubMed: 35972724

History

Published online: 3 November 2022
Published in print: November 2022
Published ahead of print: 5 October 2022
Published ahead of production: 16 August 2022

Permissions

Request permissions for this article.

Authors

Affiliations

Department of Infectious Diseases, Alfred Health, Melbourne, Australia.
Department of Infectious Diseases, Monash Health, Clayton, Australia.
Christy Ko
Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Australia.
Adam Ehm
Living Positive Victoria, Melbourne, Australia.
Jessica O'Bryan
Department of Infectious Diseases, Alfred Health, Melbourne, Australia.
Department of Infectious Diseases, Monash Health, Clayton, Australia.
James McMahon
Department of Infectious Diseases, Alfred Health, Melbourne, Australia.
Department of Infectious Diseases, Monash Health, Clayton, Australia.
Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Australia.
Department of Infectious Diseases, Alfred Health, Melbourne, Australia.
Department of Infectious Diseases, Monash Health, Clayton, Australia.
Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Australia.
Jennifer Hoy
Department of Infectious Diseases, Alfred Health, Melbourne, Australia.
Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Australia.
Department of Infectious Diseases, Alfred Health, Melbourne, Australia.
Department of Infectious Diseases, Monash Health, Clayton, Australia.
Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Australia.

Notes

Address correspondence to: Jillian Lau, Department of Infectious Diseases, The Alfred Hospital, 55 Commercial Road, Melbourne 3004, Australia [email protected]

Authors' Contributions

All authors contributed to study protocol development, survey design, and participant recruitment. Authors M.W., J.O., and J.L. were involved in ethics approval and data analysis. All of the listed coauthors have reviewed and approved the article before submission.

Author Disclosure Statement

No competing financial interests exist.

Funding Information

No funding was received for this article.

Metrics & Citations

Metrics

Citations

Export citation

Select the format you want to export the citations of this publication.

View Options

Get Access

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.

Society Access

If you are a member of a society that has access to this content please log in via your society website and then return to this publication.

Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

View options

PDF/EPUB

View PDF/ePub

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Copy the content Link

Share on social media

Back to Top